A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2004
12/08/2004	CN1553952A Materials and methods to promote repair of nerve tissue
12/08/2004	CN1553916A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
12/08/2004	CN1553910A Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/08/2004	CN1553909A Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
12/08/2004	CN1553905A Novel urea compounds as vanilloid receptor antagonist for treatment of pains
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553812A 自体t-细胞疫苗材料和方法 Autologous vaccines Materials and Methods Cell t-
12/08/2004	CN1553804A Combinations for the treatment of inflammatory disorders
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553797A Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
12/08/2004	CN1553771A Nicotine-containing oral dosage form
12/08/2004	CN1552894A Corn peptide and its preparation and use
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552440A Removing albumin nerve growth factor agent
12/08/2004	CN1552419A Chinese medicine for stopping narcotic drug
12/08/2004	CN1552415A Medicine for treating dementia and preparing method thereof
12/08/2004	CN1552384A Yilingjing pills and their preparation
12/08/2004	CN1552370A Compound fresh herba dendrobill pills and their preparation
12/08/2004	CN1552365A Migraine treating pills and their preparation
12/08/2004	CN1552364A Xuefu ecchymosis eliminating pills and their preparation
12/08/2004	CN1552359A Compound falsepimpernel pills and their preparation
12/08/2004	CN1552356A Sedative pill and preparing method thereof
12/08/2004	CN1552352A Medicine for preventing senile dementia
12/08/2004	CN1552333A Medicine for preventing depression
12/08/2004	CN1552331A Improvement of chronic mild stress BALB/C mouse depression by compound 7-carbonyl epiandrosterone
12/08/2004	CN1552315A 治疗组合物 The therapeutic composition
12/08/2004	CN1179047C Method for introducing substances into cells and use of said method
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004	CN1178934C Benzofurane derivatives
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178927C Histamine H3 receptor ligands
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178914C 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
12/08/2004	CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/08/2004	CN1178911C Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178890C Method for extracting hypericin from hypericum perforatum
12/08/2004	CN1178667C Glycosaminoglycans having average molecular weight equal to 2400 D suitable for treatment of senile dementia
12/08/2004	CN1178662C Oral 2-methyl-thieno-benzodiazepine formulation
12/07/2004	US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004	US6828440 Analgesics; side effect reduction
12/07/2004	US6828351 Methods and compositions for regulating memory consolidation
12/07/2004	US6828350 Inhibiting the activity of a picornavirus 3C protease or a cysteine protease with a composition having an orthohydroxy keto aryl core structure
12/07/2004	US6828345 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828332 Piperidine derivatives as reuptake inhibitors
12/07/2004	US6828330 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
12/07/2004	US6828329 Aryl fused substituted 4-oxy-pyridines
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828325 A benzoxazolopiperazine derivative useful for treating Parkinson's diseases, schizophrenia, anxiety and depression
12/07/2004	US6828324 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
12/07/2004	US6828322 Triazolo-pyridazine derivatives as ligands for GABA receptors
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6828314 Modulation of the activity of serotonin receptors (5-HT) to treat diseases such as anxiety, depression or obesity
12/07/2004	US6827947 Film coating
12/07/2004	US6827932 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
12/07/2004	CA2316921C Aryl fused azapolycyclic compounds
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/07/2004	CA2127374C Novel derivative of isoindolinone, its preparation and pharmaceutical compositions containing it
12/02/2004	WO2004104030A2 Peptides modulating the activity of the engrailed transcription factor
12/02/2004	WO2004104028A1 Anti-inflammatory agents
12/02/2004	WO2004104009A1 Process for making spirolactone compounds
12/02/2004	WO2004104004A2 Triaza-spiro compounds as nociceptin analogues and uses thereof
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103991A1 2-substituted piperidines, focused library and a pharmaceutical compound
12/02/2004	WO2004103988A1 Sulfur-containing proanthocyanidin oligomer composition and process for producing the same
12/02/2004	WO2004103987A1 Drug for nervous disorder
12/02/2004	WO2004103971A1 Cyclic aminophenyl sulfamate derivative
12/02/2004	WO2004103954A1 Amide derivative
12/02/2004	WO2004103411A1 Migraine remedy
12/02/2004	WO2004103394A2 Method and compositions for nerve regeneration
12/02/2004	WO2004103386A1 New use of baicalin for treating anxiety
12/02/2004	WO2004103381A1 Glycosaminoglycans for treatment emotional dysfunctions
12/02/2004	WO2004103372A1 Pharmaceutical compositions of varenicline
12/02/2004	WO2004103368A1 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity
12/02/2004	WO2004103367A1 Benzothiazole derivatives and use thereof in the treatment of diseases relates to the adenosine a2a receptor
12/02/2004	WO2004103359A1 Pharmaceutical combination comprising modafinil and another drug
12/02/2004	WO2004103356A2 Treatment of emotional dysregulation
12/02/2004	WO2004103352A1 Ras antagonists for treating neurodegenerative disorders
12/02/2004	WO2004094431A3 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
12/02/2004	WO2004093867A3 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
12/02/2004	WO2004083363A3 Therapeutical use of anti-myelin associated glycoprotein (mag) antibodies
12/02/2004	WO2004074243A3 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
12/02/2004	WO2004073653A8 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same
12/02/2004	WO2004069840A3 Production of tetrahydroquinoline benzofurans
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
12/02/2004	WO2002051981A3 Defects in periaxin associated with myelinopathies
12/02/2004	US20040242890 Agonists of beta-adrenoceptors

1 ... 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 ... 1833